Show news: from last 30 days (default), 60 days, 90 days, last visit or all

Glycopyrronium oral solution authorized for severe drooling in the UK

28th July 2016

European Medicines Agency has authorized a glycopyrronium 320microgram/mL oral solution (Sialanar; Proveca) for the treatment of severe drooling in children >3 years and adolescents with neurological conditions. The committee for medicinal products for human use, had previously issued a negative opinion for wider use in patients with mild-moderate drooling, however following re-application, authorization has been granted for severe drooling.

click here to view